B+
Bull case
35%
Probability
Target price
$5.30
-73.1% vs current
CSTL
Castle BiosciencesFNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
40%
Probability
Target price
$3.60
-81.7% vs current
B-
Bear case
25%
Probability
Target price
$2.40
-87.8% vs current
AI sentiment snapshot
Latest data as of 2025-11-29
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
0.0
Score
AI commentary
Market tone is cautious-to-mixed with emphasis on reimbursement newsflow and quarterly results as primary drivers; recent trading shows low absolute prices and elevated volatility suggesting risk-averse positioning [#PR-2024-11-01], [#10-Qp34]. Analysts and investors focus on near-term cash runway and adoption metrics.
RankAlpha Sentiment AI - 2025-11-29
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
-eventUpcoming clinical / product updatesHigh impact
Potential assay validation or commercialization updates that could materially affect revenue guidance and reimbursement adoption [#10-Qp12].
2026-02-20catalystQuarterly earnings miss / guidance cutHigh impact
Weak revenue or slower test adoption could trigger downward revisions and near-term selling pressure [#10-Qp34].
2026-06-30catalystReimbursement / payer expansionHigh impact
Broader payer coverage for diagnostic tests could increase addressable market and margins [#PR-2024-11-01].
Recommendation
N/A
No formal recommendation provided.
As of 2025-11-29 • Updated nightlySource: Internal modelMethodology